Abstract. Marinesco bodies (MBs) are ubiquitinated intranuclear inclusions observed in nigral pigmented neurons. They increase in number during aging, and their formation is considered to represent a cellular reaction to stress, but is not always associated with neuronal degeneration. We conducted immunohistochemical studies on MBs abundant in myotonic dystrophy brains and compared their nature with that of neuronal intranuclear inclusions (NIIs) in polyglutamine diseases. First, we examined the relationship between MBs and polyglutamine proteins and demonstrated that one of the polyglutamine proteins, ataxin-3, as well as a 19S proteasomal protein, was preferentially recruited into MBs even in the absence of expanded polyglutamine. This indicates that an alternative mechanism during the formation of MBs that is not related to polyglutamine expansion or neuronal degeneration may recruit ataxin-3 into nuclear inclusions in a protein-specific manner. Secondly, we investigated the relationship between MBs and promyelocytic leukemia protein (PML), a nuclear matrix-associated protein that is normally localized to intranuclear punctate structures (PML nuclear bodies) and is known to reorganize itself in association with polyglutamine aggregation. In nigral pigmented neurons in myotonic dystrophy, spherical, hemispherical or rod-like PML-immunoreactive structures, in addition to punctate structures, were observed in their nuclei. Similar PML redistribution was also observed in nigral pigmented neurons in aged controls and cases of hepatic encephalopathy, 2 other conditions in which abundant MBs are formed. Double immunofluorescence study revealed that these PML-positive structures undergo morphological changes in association with ubiquitin accumulation during MB formation. It is therefore indicated that PML reorganization does not represent a specific nuclear event involved in the pathogenesis of polyglutamine diseases, but may commonly occur during the formation of intranuclear inclusions as a reaction against various stresses that involve the ubiquitin-proteasome pathway.
INTRODUCTION
A cytopathological hallmark of polyglutamine diseases is the presence of neuronal intranuclear inclusions (NIIs) harboring disease-related proteins containing abnormally expanded polyglutamines (1) . Since the artificial overexpression of truncated proteins containing expanded polyglutamines in some cellular or animal models results in the formation of intranuclear aggregates and causes cell death (2) (3) (4) (5) (6) , it has been speculated that the NII formation plays a key role in the pathogenesis of polyglutamine diseases. Recently, several studies indicated that a nuclear matrix-associated protein, promyelocytic leukemia protein (PML), is redistributed during the formation of NIIs (2, (7) (8) (9) (10) . PML is a major component of nuclear subdomains, namely PML nuclear bodies, which appear normally as punctate structures scattered in the nuclei (11) . In cells transfected with mutant ataxin-1 (2) or mutant ataxin-3 (7), PML altered its normal distribution and was colocalized to nuclear aggregates formed by mutant proteins. A similar reorganization of PML nuclear bodies around NIIs was also observed in human brains with dentatorubral-pallidoluysian atrophy (DRPLA), Machado-Joseph disease (MJD)/spinocerebellar ataxia type 3 (SCA3) (8, 9) , and SCA7 (10) . Because PML mediates multiple apoptotic pathways (12, 13) and the disruption of PML nuclear bodies plays a fundamental role in the oncogenic mechanism of acute promyelocytic leukemia (14) , it was speculated that a critical step in polyglutamine pathogenesis also involves the alternation of this subnuclear domain (2, 9, 15) . One of the questions to be addressed is, therefore, how PML is involved in the formation of NIIs and neurodegeneration.
In this study, we focused on another example of ubiquitinated intranuclear inclusions in the pigmented neurons of the substantia nigra, Marinesco bodies (MBs), which are formed abundantly in the absence of expanded polyglutamine. Because their abundance in several conditions (e.g. aging [16, 17] , hepatic encephalopathy [18] , or myotonic dystrophy [19] ) is not necessarily associated with degenerative changes in the nigral pigmented neurons (18) , this study provides us with an opportunity to observe the formation process of nuclear inclusions not related to polyglutamine expansion or cell degeneration. We previously reported that MBs of aged controls and those of patients with hepatic encephalopathy contain Fig. 1 . Immunohistochemical studies of nigral pigmented neurons in myotonic dystrophy. a: MBs were immunopositive for anti-ubiquitin antibody (arrow), which were distinct from nucleoli counterstained by hematoxylin (arrowhead). b: Double immunohistochemical staining with antibodies against ataxin-2 and ubiquitin revealed that ataxin-2 was immunoreactive in the nucleoplasm, but not in the nucleoli (arrowhead) or MBs (arrows). c: Ataxin-3 immunolabeling was manifested as intranuclear inclusions. Fig. 2 . Double immunofluorescence staining of MB in myotonic dystrophy. a: Ubiquitin immunoreactivity. b: Ataxin-3 immunoreactivity. c: Merged image of (a) and (b). Ataxin-3 is localized in the core of MBs, surrounded by ubiquitin. These images of the same neuron were obtained by confocal microscopy. a polyglutamine protein, ataxin-3, in the absence of expanded polyglutamine (20, 21) . As ubiquitin and ataxin-3 are commonly recruited into NIIs of polyglutamine diseases (22) , MBs share the immunohistochemical characteristics of NIIs seen in polyglutamine diseases. In this study, these immunohistochemical characteristics of MBs were confirmed in cases of myotonic dystrophy. In addition, we demonstrated for the first time that the reorganization of PML nuclear bodies occurs during MB formation, independent of polyglutamine expansion.
MATERIALS AND METHODS

Immunohistochemical Examination of Nigral Pigmented Neurons in Myotonic Dystrophy
The clinical subjects comprised 7 cases of myotonic dystrophy (Table) . The diagnosis was made on the basis of characteristic clinical features, such as frontal baldness, cataracts, cardiac conduction abnormalities, testicular atrophy, and endocrine abnormalities, in addition to the presence of clinical and electrical myotonia and distal-dominant myopathy (23) . Each case showed the neuropathological features of myotonic dystrophy, including abundant thalamic inclusions (19) , neurofibrillary tangles unaccompanied by senile plaques in the parahippocampal gyrus (24) , and myelin loss of the white matter in the anterior temporal lobes (25, 26) , as confirmed by TM, MO, SK, and MH.
The examination of patient tissues was conducted after written consent was provided by the next of kin and with the approval of the institutional committee. Formalin-fixed paraffinembedded blocks of the midbrain were examined. Four-m-thick sections were immunohistochemically stained by standard avidin-biotin-peroxidase complex (ABC) methods. The following antibodies were used: anti-ubiquitin (dilution 1: 10,000, mouse monoclonal, Chemicon, Temecula, CA), antipolyglutamine 1C2 (dilution 1:10,000, mouse monoclonal, Chemicon), anti-ataxin-2 15F6 (dilution 1:100, mouse monoclonal, IgM class, Imochem, Christchurch, New Zealand), antiataxin-3 A3C-1 (dilution 1:1,000, rabbit polyclonal) (20) , anti-PML (dilution 1:3,000, rabbit polyclonal, MBL, Nagoya, Japan) (27) , and anti-ATPase subunit MSS1 of 19S proteasome (dilution 1:10,000, rabbit polyclonal, Affiniti, Exeter, UK). To expose the antigenic epitopes, sections were treated as follows: immersed in 99% formic acid for 5 min for anti-ubiquitin, autoclaved in 10 mM citrate buffer (PH 6.0) for 20 min for 1C2, 15F6, anti-PML, and anti-MSS1, or irradiated in a microwave oven for 5 min ϫ 3 times in 0.01 M citrate buffer (PH 6.0) for A3C-1. The sections were incubated with one of the primary antibodies for 48 hours (h) at 4ЊC. After incubation with an appropriate biotinylated secondary antibody, color was developed using ABC (ABC Elite, Vector, Burlingame, CA) with diaminobenzidine as the chromogen. If necessary, nickel ammonium chloride was added to enhance immunolabeling (28) .
The relationship between the ubiquitin epitope and either the ataxin-3 or PML epitope was examined by double immunofluorescence labeling. After being autoclaved in the citrate buffer as above, sections were incubated for 48 h with a mixture of anti-ubiquitin (1:10,000) and either A3C-1 (1:50) or anti-PML (1:300) antibodies. These sections were then incubated for 2 h with a mixture of anti-mouse IgG antibody coupled with Rhodamine red (1:200, emission peak 590 nm, Jackson Immuno Research, West Grove, PA) and anti-rabbit IgG antibody coupled with FITC (1:200, emission peak 518 nm, Cappel, Durham, NC). Other sections were incubated with a mixture of antimouse IgG antibody coupled with FITC (1:200, emission peak 518 nm, Cappel) and anti-rabbit IgG antibody coupled with Texas red (1:200, emission peak 596 nm, ICN, Aurora, Ohio) for comparison, giving essentially the same results. Confocal images were obtained through a Leica TCS-SP laser confocal microscope (Heidelberg, Germany).
Immunohistochemical Examination of the Extranigral Regions in Myotonic Dystrophy and the Substantia Nigra in Hepatic Encephalopathy, Aged and Young Controls
Sections of the thalamus, cerebellum, temporal lobe including hippocampus, and spinal cord were examined in all 7 cases of myotonic dystrophy. In addition, sections of the midbrain were examined in 3 cases of hepatic encephalopathy, 5 aged controls, and 2 young controls. The latter two showed no morphological abnormalities in the central nervous system (Table) . controls, respectively, on confocal images at the optical plane showing the maximum cross-sectional areas, using the NIH image.
RESULTS
In all the cases examined there was neither apparent neuronal loss nor gliosis in the substantia nigra. MBs, ubiquitin-positive intranuclear inclusions (Fig. 1a) , were abundantly observed in nigral pigmented neurons in the cases of myotonic dystrophy, hepatic encephalopathy, and aged controls, but not in the young controls (Table) . Immunohistochemical studies for polyglutamine proteins were conducted on nigral pigmented neurons in myotonic dystrophy. Immunoreactivity for 1C2 was not detected in the nuclei. Immunoreactivity for ataxin-2, the protein encoded by the SCA2 gene, was observed in the nucleoplasm of pigmented neurons, but not nucleoli or MBs (Fig. 1b) . In contrast, MBs were immunopositive for ataxin-3, the protein encoded by the MJD/SCA3 gene (Fig. 1c) , and the double immunofluorescence study demonstrated that ataxin-3 and ubiquitin epitopes were colocalized in the inclusions, with the former always accumulating in the center, surrounded by the latter (Fig. 2a-c) .
MBs were immunopositive for MSS1, a subunit of ATPase of 19S proteasome, which is involved in the ubiquitin-proteasome pathway for protein degradation (Fig. 3a) . In about half of the nigral pigmented neurons in myotonic dystrophy, PML-like immunoreactivity was seen as intranuclear fine granules, as described in the literature (PML nuclear bodies) (11) (Fig. 3b) . However, in other pigmented neurons, PML-like immunoreactivity was seen as larger-sized spherical, hemispherical, or rodlike structures (Fig. 3c, d ). Similar PML redistribution was also observed in nigral pigmented neurons in cases of hepatic encephalopathy (Fig. 3e, f) and aged controls (Fig. 3g, h ), in which abundant MBs were seen. In contrast, in neurons in the thalamus, cerebellum, temporal lobe, and spinal cord in myotonic dystrophy, where no intranuclear inclusions were observed, PML-like immunoreactivity was present only as a finely granular pattern (Fig. 3i, j) . The double immunofluorescence study with anti-ubiquitin and anti-PML antibodies was conducted in the young controls and cases of myotonic dystrophy to examine the relationship between MBs and PML. In nigral pigmented neurons in the young controls in which no MBs were seen, 5 to 10 PML-positive fine granules were observed in the nuclei, whereas no ubiquitin-positive structures were demonstrated (Fig. 4a) . On the other hand, in myotonic dystrophy, several kinds of PML and/ or ubiquitin positive intranuclear structures were seen in nigral pigmented neurons. They were classified as follows: group 1, several PML-positive fine granules not colocalized to ubiquitin epitope, which were similar to those observed in the young controls (Fig. 4b) ; group 2, larger PML-positive spherical or hemispherical structures containing the ubiquitin epitope (Fig. 4c) , coexisting with a few PML-positive fine granules; group 3, hemispherical, spherical, or rod-like PML-positive structures containing the ubiquitin epitope, which were adjacent to much larger ubiquitin-positive spheres (Fig. 4d, e) ; group 4, large ubiquitin-positive spheres. These spheres were flanked by PML-positive microparticles that were smaller than the PML-positive granules observed in group 1 (Fig.  4f) . The PML-positive granules seen in group 1 were rarely observed in the neurons of groups 3 and 4. The PML redistribution shown in groups 2 to 4 was always associated with ubiquitin accumulation. We measured the areas of the PML-and/or ubiquitin-positive structures on confocal images showing the maximum cross-sectional areas. In myotonic dystrophy, the larger areas occupied by either PML-positive or ubiquitin-positive structures were compared among each group. They were smallest in group 1, medium-sized in group 2, and largest in groups 3 and 4 ( Fig. 5a ). Non-parametric analysis using the Kruskal-Wallis test revealed that their size difference among the 3 groups was statistically significant (p Ͻ 0.0001). We also measured the areas of the PML-positive granules in the young controls (Fig. 5b ) and they were as small as those in group 1 myotonic dystrophy, verified by non-parametric analysis using the Mann-Whitney Utest.
DISCUSSION
MBs are the eosinophilic intranuclear inclusions observed in pigmented neurons in the substantia nigra. Although their pathogenesis remains to be elucidated, it is speculated that their formation may represent a cellular reaction to a certain kind of stress, because they increase in number during aging (16, 17) and under pathological conditions related to metabolic errors, such as hepatic encephalopathy (18) . This hypothesis is further supported by the fact that MBs contain ubiquitin (29) , which plays a crucial role in the removal of damaged proteins (30) . We have previously demonstrated that one of the polyglutamine proteins, ataxin-3, is recruited into MBs in the brains of aged people and patients with hepatic encephalopathy (20, 21) . In this study, the recruitment of ataxin-3 into MBs was also confirmed in myotonic dystrophy, another condition known to show numerous MBs (19) . These observations indicate that ataxin-3 is a common component of MBs, regardless of their pathological origin. In polyglutamine diseases, wild-type polyglutamine proteins are recruited into NIIs formed in the presence of pathologically-expanded polyglutamine, which leads to the hypothesis that an interaction between expanded and non-expanded polyglutamines is a prerequisite for the nuclear translocation of wild-type polyglutamine proteins (22, 31) . In our studies, however, wild-type ataxin-3 was recruited into MBs in the absence of expanded polyglutamine. It is therefore suggested that ataxin-3 may be recruited into nuclear inclusions in a protein-specific manner, independent of polyglutamine-polyglutamine interaction. Interestingly, ataxin-3 was always concentrated in the center of MBs surrounded by the ubiquitin epitope in myotonic dystrophy, as shown in aged controls and cases of hepatic encephalopathy (20, 21) . Furthermore, this characteristic morphological feature is also shared with NIIs of MJD/SCA3 brains (20) . Although the physiological and pathological roles of ataxin- 3 have not yet been clarified, these observations suggest that ataxin-3, like ubiquitin, may be involved in cellular reactions to stress, and is commonly recruited into intranuclear inclusions even before ubiquitin accumulation.
Another intriguing feature revealed by this study is the morphological changes of PML nuclear bodies in nigral pigmented neurons. These alternations were commonly observed in myotonic dystrophy, hepatic encephalopathy (Fig. 3e, f) , and aging (Fig. 3g, h ), in which abundant MBs were formed, while they were not demonstrated in the young controls in whom MBs were absent. Furthermore, this alteration of PML was not found in the extranigral areas (thalamus, cerebellum, temporal lobe, and spinal cord) in myotonic dystrophy brains. It is therefore likely that the morphological changes of PML nuclear bodies are not specific to myotonic dystrophy, but are linked to the formation of MBs in general, regardless of their underlying condition. The double immunofluorescence study revealed that some PML-containing structures were intermingled with ubiquitin-positive structures, which probably represent the intermediate phases of MB formation. Our morphometric approach further clarified that progressive ubiquitin accumulation was associated with a gradual increase in the size of these structures. These observations suggest the following hypothesis for the process of MB formation: Ubiquitin, which initially accumulates within PML nuclear bodies (group 2), may undergo subsequent modification through progressive enlargement (group 3), finally leading to the formation of large intranuclear structures, MBs, in which PML nuclear bodies are disrupted (group 4).
Although the association of PML with intranuclear aggregates has been described in DRPLA, MJD/SCA3 (8, 9) , and SCA7 (10) brains, this is the first study that demonstrated how ubiquitin and PML interrelate during the formation of intranuclear inclusions in human brains. More importantly, our study demonstrated that PML involvement in the formation of intranuclear inclusions was not restricted to the pathological processes triggered by polyglutamine expansion, but was also shared with other pathological states. The function of PML nuclear bodies is not fully understood. Since they are involved in apoptosis (12, 13) , it has been hypothesized that their alternation may be closely linked to neuronal degeneration in polyglutamine diseases (2, 15) . However, because MB formation is not always associated with neuronal depletion, as shown in this study, the reorganization of PML nuclear bodies is not necessarily linked to neuronal death. It was recently demonstrated that mutated forms of the influenza virus nucleoprotein, which are misfolded and are therefore usually rapidly degraded by proteasomes, accumulated within PML nuclear bodies when proteasomes were inhibited. Their accumulation in PML nuclear bodies was followed by the recruitment of proteasomes and molecular chaperones (32) . It is therefore suggested that PML nuclear bodies serve as an intranuclear center for the ubiquitin-proteasomal degradation, where misfolded proteins are accumulated (32 studies on SCA1 (33) and MJD/SCA3 (7) have revealed that proteasomes and molecular chaperones were also recruited into nuclear aggregates of mutant proteins formed in association with PML, both in human brains and in transfected cells. In our study also, one of the proteasomal proteins, MSS1, was recruited into MBs. In addition, the PML redistribution in nigral pigmented neurons was always associated with ubiquitin accumulation, and neither occurred individually. It is therefore suggested that activation of the ubiqutin-proteasomal pathway to degrade misfolded proteins (similar to that observed in viral experiments) occurs in both the nuclear aggregates of polyglutamine diseases and MBs. These observations indicate that the reorganization of PML nuclear bodies does not represent a specific nuclear event in the neurodegeneration of polyglutamine diseases, but may occur as a common cellular reaction against an overload of misfolded proteins, triggered by either viral infection, polyglutamine expansion, or cellular stress.
In summary, in this study of MBs we have clarified that at least 2 cellular events, the translocation of ataxin-3 into the nucleus and the redistribution of PML nuclear bodies (which have previously been considered to be specifically related to polyglutamine pathology) can occur independently of polyglutamine expansion. These events may rather occur as a cellular reaction against various stresses, which finally leads to the formation of intranuclear inclusions, such as MBs. Furthermore, the occurrence of these events in neurons without any evidence of degeneration, as shown in our study, indicates that cell death is not a necessary accompaniment to the formation of nuclear inclusions. Further investigations into the pathomechanism of MBs and their possible relation to cell death may be useful to elucidate the pathological relevance of intranuclear inclusions in various disorders, including polyglutamine diseases.
